Alliance Wealth Advisors »

Halozyme Therapeutics shares owned by Alliance Wealth Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Alliance Wealth Advisors from 13F filings

Historical chart of Alliance Wealth Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Alliance Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Alliance Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $501k 12k 40.68
2023-12-31 $355k 9.6k 36.96
2023-09-30 $321k 8.4k 38.20
2023-06-30 $282k 7.8k 36.07